Literature DB >> 6214430

Second-look laparoscopy in infertility surgery: therapeutic and prognostic value.

S G Raj, J F Hulka.   

Abstract

Sixty infertile women underwent infertility surgery followed by "second-look laparoscopy" (SLL). All these women had undergone detailed fertility workups, including a diagnostic laparoscopy prior to surgery. The tuboovarian adhesive disease was staged according to the severity of the disease and compared with findings at SLL. Sixty percent of adnexa showed improvement at SLL. During SLL, newly formed adhesions were lysed and stenotic fimbrial ostia dilated. Optimal time for SLL was 4 to 8 weeks after surgery. From these observations, we suggest that SLL provides further opportunity to lyse re-formed adhesions and may have prognostic and therapeutic benefits after laparotomy for lysis of adhesions.

Entities:  

Keywords:  Biology; Delivery Of Health Care; Endoscopy; Examinations And Diagnoses; Genital Effects, Female; Genitalia; Genitalia, Female; Health; Health Services; Infertility--women; Laparoscopy; North Carolina; Physical Examinations And Diagnoses; Physiology; Pregnancy; Reproduction; Surgery; Time Factors; Treatment; Urogenital System

Mesh:

Substances:

Year:  1982        PMID: 6214430

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

Review 1.  Abdominal adhesions: intestinal obstruction, pain, and infertility.

Authors:  W W Vrijland; J Jeekel; H J van Geldorp; D J Swank; H J Bonjer
Journal:  Surg Endosc       Date:  2003-03-14       Impact factor: 4.584

Review 2.  Postoperative procedures for improving fertility following pelvic reproductive surgery.

Authors:  James M N Duffy; Neil Johnson; Gaity Ahmad; Andrew Watson
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

3.  Factors influencing the success of microsurgery for distal tubal occlusion.

Authors:  T J Laatikainen; A K Tenhunen; P K Venesmaa; D L Apter
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

4.  A first-in-human, randomized, controlled, subject- and reviewer-blinded multicenter study of Actamax™ Adhesion Barrier.

Authors:  Geoffrey H Trew; George A Pistofidis; Sara Y Brucker; Bernhard Krämer; Nicole M Ziegler; Matthias Korell; Henning Ritter; Alex McConnachie; Ian Ford; Alison M Crowe; Trudy D Estridge; Michael P Diamond; Rudy L De Wilde
Journal:  Arch Gynecol Obstet       Date:  2016-11-14       Impact factor: 2.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.